- Why the nitroglycerin goes under the tongue:
- First-pass metabolism, sublingual bypass, bioavailability of intravenous vs oral, and why oral nitroglycerin would barely work.
- An antibiotic that runs up the INR:
- Warfarin-antibiotic interaction through CYP inhibition and gut-flora effects, the inducer contrast, and narrow therapeutic index.
- When the same dose works differently:
- Codeine as a CYP2D6 prodrug, poor and ultra-rapid metabolizer effects, pharmacogenetic variability, and the non-opioid alternative.
- Reversing an opioid with naloxone:
- Naloxone as a competitive antagonist that can be overcome, the short-half-life re-sedation caveat, and the competitive vs non-competitive distinction.
- Why warfarin needs INR monitoring:
- Narrow therapeutic index, TI definition, other narrow-TI drugs, and the practical implication of monitoring and not routinely stopping warfarin.
- Hepatotoxicity from too much acetaminophen:
- NAPQI metabolite, glutathione depletion, N-acetylcysteine antidote, chronic ethanol risk, and that OTC drugs still have dose limits.
- Writing a safe dental prescription:
- Required prescription elements, the ibuprofen-acetaminophen combination, dose adjustments for elderly and organ impairment, sig abbreviations, and reviewing the medication list.